Jessica DeFrank conducts behavioral and health services research for various studies funded by the US Food and Drug Administration, National Institutes of Health, Patient Centered Outcomes Research Institute (PCORI), the Agency for Healthcare Research and Quality (AHRQ), and American Cancer Society. Her areas of interest include health decision making, measurement of patient-reported outcomes and attitudes, and evaluation of health promotion programs, with a focus on cancer, screening, prescription drugs, and vaccination.
Dr. DeFrank is currently a research investigator with the INSPIRE trial: Integrated Services for Pain—Interventions to Reduce Pain Effectively. This PCORI-funded study is a large-scale, pragmatic trial to test two programs for reducing opioid use among pain patients. As part of this project, Dr. DeFrank leads survey development and a sub-study that will experimentally test an electronic tool for improving patient understanding of informed consent elements.
Dr. DeFrank has also worked extensively in the area of communicating scientific information to lay audiences and leads an experimental study testing recommended practices for communicating uncertainty about prescription drug risks.
In addition to her work in prescription drugs, Dr. DeFrank has extensive experience working in cancer-related decision-making, psycho-oncology and survivorship issues.